Lorundrostat effective for lowering BP in uncontrolled hypertension
Sep 15, 2023
Changes in office systolic BP of −14.1, −13.2, −6.9 and −4.1 mm Hg were seen with 100, 50, 12.5 mg once daily of lorundrostat and placebo.
Risk for dementia reduced in association with antihypertensive use
Sep 13, 2023
An individual patient data meta-analysis shows increased risk for dementia for those with untreated hypertension.
Rice-sized device could have big implications for brain tumor treatments
By
Aaron Dorman
Sep 12, 2023
A small implantable device, the size of a grain of rice, could be placed in the brain of cancer patients to help develop treatments, new research suggests.
Being in good shape tied to fewer mental health Rx
Sep 11, 2023
There was not an association noted between a reduced risk for medication use for adults aged 65 or more years.
DOACs reduce dementia risk versus warfarin in A-Fib
Sep 07, 2023
Significant reductions were seen in dementia risk for rivaroxaban, apixaban and dabigatran versus warfarin in a network meta-analysis.
Even five years postapproval, many drug studies remain nonpublic
Sep 01, 2023
The authors urge greater transparency of study results for drugs approved by the FDA.
Glycemic control superior with semaglutide 25 and 50 mg in Type 2 diabetes
Aug 04, 2023
Mean changes in HbA1c were significantly greater for semaglutide 25 mg or 50 mg versus 14 mg.
Medication managed by AI can help patients feel better, study shows
By
Aaron Dorman
Aug 02, 2023
New research on an AI-tool for medication management showed cost savings and effective decision-making for high-risk patients.
Solanezumab does not slow cognitive decline in preclinical Alzheimer’s disease
Jul 19, 2023
The mean change in Preclinical Alzheimer Cognitive Composite score not significantly different at 240 weeks with solanezumab or placebo.
AI helps prevent prescription dosing errors
By
Christine Birkner
Jun 02, 2023
Software company DrFirst developed an AI-powered tool to streamline medication refill and renewal requests.